Wed, December 12, 2012
Tue, December 11, 2012

Edward Tenthoff Upgraded (ALNY) to Buy and Increased Target to $25 on, Dec 12th, 2012

Edward Tenthoff of Piper Sandler, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Buy and Increased Target from $19 to $25 on, Dec 12th, 2012.

Edward, nor any peers, have made any analyst calls on ALNY in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications